JP2009518397A - 高い抗癌活性及び持続性抗マラリア活性を有するトリオキサンダイマー - Google Patents

高い抗癌活性及び持続性抗マラリア活性を有するトリオキサンダイマー Download PDF

Info

Publication number
JP2009518397A
JP2009518397A JP2008544353A JP2008544353A JP2009518397A JP 2009518397 A JP2009518397 A JP 2009518397A JP 2008544353 A JP2008544353 A JP 2008544353A JP 2008544353 A JP2008544353 A JP 2008544353A JP 2009518397 A JP2009518397 A JP 2009518397A
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
compound
mmol
nmr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008544353A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009518397A5 (enExample
Inventor
ゲアリー エイチ ポズナー
イクヒョン パイク
クリスティナ ボストニック
ウォンスク チャン
サンドラ シニシュタイ
ウィリアム アンソニー マイオ
ジョン ガエタノ ダンジェロ
ローレン エレイン ウッダード
アルヴィン ソロマン カリンダ
エイミー アール ユセラ
リンゼイ キャサリン ヘス
アンドリュー スコット ローゼンタール
ソンホ オー
アシュトリート ツェー ベーゲ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Government of the United States of America
Original Assignee
Government of the United States of America
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Government of the United States of America filed Critical Government of the United States of America
Publication of JP2009518397A publication Critical patent/JP2009518397A/ja
Publication of JP2009518397A5 publication Critical patent/JP2009518397A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/55—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound the modifying agent being also a pharmacologically or therapeutically active agent, i.e. the entire conjugate being a codrug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
    • C07D493/18—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
JP2008544353A 2005-12-08 2006-11-17 高い抗癌活性及び持続性抗マラリア活性を有するトリオキサンダイマー Pending JP2009518397A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US74854805P 2005-12-08 2005-12-08
US76512506P 2006-02-03 2006-02-03
US79481106P 2006-04-25 2006-04-25
PCT/US2006/044845 WO2007067333A2 (en) 2005-12-08 2006-11-17 Trioxane dimers having high anticancer and long-lasting antimalarial activities

Publications (2)

Publication Number Publication Date
JP2009518397A true JP2009518397A (ja) 2009-05-07
JP2009518397A5 JP2009518397A5 (enExample) 2010-01-14

Family

ID=38123365

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008544353A Pending JP2009518397A (ja) 2005-12-08 2006-11-17 高い抗癌活性及び持続性抗マラリア活性を有するトリオキサンダイマー

Country Status (10)

Country Link
US (1) US20090291923A1 (enExample)
EP (1) EP1962596A4 (enExample)
JP (1) JP2009518397A (enExample)
KR (1) KR20080081310A (enExample)
AU (1) AU2006323040A1 (enExample)
BR (1) BRPI0619759A2 (enExample)
CA (1) CA2632200A1 (enExample)
IL (1) IL191597A0 (enExample)
MX (1) MX2008007358A (enExample)
WO (1) WO2007067333A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2141499A1 (en) * 2008-07-02 2010-01-06 Apoptec AG COPD diagnosis
US8592611B2 (en) 2008-07-17 2013-11-26 The Johns Hopkins University Trioxane dimer sulfur compounds
WO2010032165A2 (en) * 2008-09-19 2010-03-25 North-West University Prodrugs of artemisinin
US8884032B2 (en) 2009-05-19 2014-11-11 The Johns Hopkins University Trioxane monomers and dimers
IN2012DN05028A (enExample) 2009-12-07 2015-10-23 Univ Johns Hopkins
CA2782110A1 (en) * 2009-12-07 2011-06-16 Johns Hopkins University N-acyloxysulfonamide and n-hydroxy-n-acylsulfonamide derivatives
US9493480B2 (en) 2011-04-15 2016-11-15 The Johns Hopkins University Monomeric trioxane amide sulfur compounds

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004028476A2 (en) * 2002-09-27 2004-04-08 Johns Hopkins University Artemisinin-derived trioxane dimers

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL121749A0 (en) * 1997-09-11 1998-02-22 Yeda Res & Dev 2,3-dioxabicycloÚ3.3.1¾nonane derivatives and antimalarial pharmaceutical compositions comprising them
US6160004A (en) * 1997-12-30 2000-12-12 Hauser, Inc. C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumor activities
US20050240034A1 (en) * 2002-05-07 2005-10-27 Mitchell Avery Artemisinin-based peroxide compounds as broad spectrum anti-infective agents

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004028476A2 (en) * 2002-09-27 2004-04-08 Johns Hopkins University Artemisinin-derived trioxane dimers

Also Published As

Publication number Publication date
EP1962596A2 (en) 2008-09-03
WO2007067333A3 (en) 2008-01-31
KR20080081310A (ko) 2008-09-09
BRPI0619759A2 (pt) 2011-10-18
US20090291923A1 (en) 2009-11-26
EP1962596A4 (en) 2010-09-22
CA2632200A1 (en) 2007-06-14
AU2006323040A1 (en) 2007-06-14
WO2007067333A2 (en) 2007-06-14
IL191597A0 (en) 2009-02-11
MX2008007358A (es) 2008-11-10

Similar Documents

Publication Publication Date Title
US11459327B1 (en) Cycloalkyl and hetero-cycloalkyl inhibitors, preparation methods therefor, and use thereof
JP2023508482A (ja) スピロ環含有キナゾリン化合物
WO2021027911A1 (zh) 新型螺环类K-Ras G12C抑制剂
EP2947086B1 (en) Novel fused pyrimidine compound or salt thereof
RS51226B (sr) Derivati azapeptida kao inhibitori hiv proteaze
JP2017039730A (ja) Hsp90関連病態の治療のために有用なポコキシム複合物
EP1043988A1 (en) C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumour activities
US20250195475A1 (en) Cdk2 inhibitor and preparation method and use thereof
JP7475370B2 (ja) ブルトン型チロシンキナーゼ阻害剤としての置換されている1-アミノ-1h-イミダゾール-5-カルボキサミド
US20250032623A1 (en) Heterobifunctional compounds and their use in treating disease
CN113620969B (zh) 带桥环的环己烷二羧酸衍生物及其药物组合物和应用
US20090291923A1 (en) Trioxane dimers having high anticancer and long-lasting antimalarial activities
US20110257111A1 (en) Hydroxyethlamino Sulfonamide Derivatives
CN103304573A (zh) 石蒜碱类化合物在制备抗肿瘤药物的应用
CN101325874A (zh) 具有高抗癌活性和长效抗疟活性的三噁烷二聚物
CA2749496A1 (en) Compositions and methods of use
JP6727231B2 (ja) 癌および糖尿病の治療に有用なエポキシアズレン誘導体
CN111377854A (zh) Cxcr4抑制剂及其应用
RU2809516C1 (ru) Производное (S)-4-оксо-N-(1,2,3,10-тетраметокси-9-оксо-5,6,7,9-тетрагидробензо[a]гептален-7-ил)пентанамида и его применение
EP4534542A1 (en) Thiosugar based isothiocyanates and uses thereof
CN103450164B (zh) 格尔德霉素衍生物及其制备方法和用途
AU2024308508A1 (en) Heterobifunctional compounds and methods of use thereof
EP4365175A1 (en) Novel benzopyran derivative and use thereof
WO2022191092A1 (ja) キノリン化合物、hnmt阻害剤、及びadhd、ナルコレプシー又はアルツハイマーの予防・治療剤
EA051754B1 (ru) Спироиндолиновые ингибиторы kif18a

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20091117

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20091117

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121105

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130401